Embla Medical hf./DKr EMBLA
08:00
10:00
12:00
13:55
15:55
1D1W1MYTD1Y5YMAX
About Embla Medical hf.
Embla Medical hf., headquartered in Reykjavik, Iceland, specializes in non-invasive orthopedic products, focusing on prosthetics, neuro orthotics, bracing, and supports. The company operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. Its product portfolio includes mechanical and bionic prosthetic devices, bracing solutions for various body parts, and patient care services for individuals with limb loss or musculoskeletal conditions. Originally founded as Össur hf. in 1971, the company rebranded to Embla Medical hf. in April 2024 to reflect its expanded scope and unified purpose. Embla Medical serves a global market, with operations across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's strategic positioning is strengthened by its diverse brand portfolio, including Össur, Fior & Gentz, College Park, and ForMotion, enabling it to offer comprehensive mobility solutions worldwide.
Ticker
DKr EMBLA
Sector
Primary listing
CSE
Employees
4,195
Headquarters
Reykjavik, Iceland
Website
EMBLA Metrics
BasicAdvanced
kr 13B
24.83
kr 1.23
0.46
-
Price and volume
Market cap
kr 13B
Beta
0.46
52-week high
kr 37.90
52-week low
kr 26.50
Average daily volume
57K
Financial strength
Current ratio
1.479
Quick ratio
0.827
Long term debt to equity
49.751
Total debt to equity
60.456
Interest coverage (TTM)
6.39%
Profitability
EBITDA (TTM)
945.006
Gross margin (TTM)
62.30%
Net profit margin (TTM)
8.97%
Operating margin (TTM)
13.43%
Effective tax rate (TTM)
22.51%
Revenue per employee (TTM)
kr 1,384,680
Management effectiveness
Return on assets (TTM)
4.77%
Return on equity (TTM)
9.98%
Valuation
Price to earnings (TTM)
24.83
Price to revenue (TTM)
2.228
Price to book
14.7
Price to tangible book (TTM)
-252.12
Price to free cash flow (TTM)
20.631
Free cash flow yield (TTM)
4.85%
Free cash flow per share (TTM)
1.478
Growth
Revenue change (TTM)
8.63%
Earnings per share change (TTM)
21.96%
3-year revenue growth (CAGR)
8.92%
10-year revenue growth (CAGR)
6.76%
3-year earnings per share growth (CAGR)
24.25%
10-year earnings per share growth (CAGR)
5.43%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Embla Medical hf. stock?
Embla Medical hf. (EMBLA) has a market cap of DKr13B as of February 14, 2026.
What is the P/E ratio for Embla Medical hf. stock?
The price to earnings (P/E) ratio for Embla Medical hf. (EMBLA) stock is 24.83 as of February 14, 2026.
Does Embla Medical hf. stock pay dividends?
No, Embla Medical hf. (EMBLA) stock does not pay dividends to its shareholders as of February 14, 2026.
When is the next Embla Medical hf. dividend payment date?
Embla Medical hf. (EMBLA) stock does not pay dividends to its shareholders.
What is the beta indicator for Embla Medical hf.?
Embla Medical hf. (EMBLA) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.